back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-02-04 15:08 Tx date 2025-01-31 |
$DTC
Defence Therapeutics Inc. |
Plouffe, Sébastien
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+200,000 vol |
1,000,000 | |
| Filed 2025-02-03 16:16 Tx date 2025-01-31 |
$DTC
Defence Therapeutics Inc. |
Meterissian, Sarkis
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+50,000 vol |
250,000 | |
| Filed 2024-12-26 14:39 Tx date 2024-12-19 |
$DTC
Defence Therapeutics Inc. |
Theodorou, Elias
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
100,000 | ||
| Filed 2024-11-18 12:12 Tx date 2024-11-08 |
$DTC
Defence Therapeutics Inc. |
Selivanova, Svetlana
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
100,000 | ||
| Filed 2024-11-18 12:09 Tx date 2024-11-08 |
$DTC
Defence Therapeutics Inc. |
Selivanova, Svetlana
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-11-15 16:43 Tx date 2024-11-15 |
$DTC
Defence Therapeutics Inc. |
Cesarone, Carrie
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-285.00
-500 vol $0.57 each |
115,500 | |
| Filed 2024-10-01 17:35 Tx date 2024-09-26 |
$DTC
Defence Therapeutics Inc. |
Lefrancois, Philippe
4 - Director of Issuer
Holder: Gestion Philippe Lefrancois Inc. (Indirect Ownership)
|
Options
50 - Grant of options
|
+100,000 vol |
100,000 | |
| Filed 2024-10-01 17:34 Tx date 2024-09-26 |
$DTC
Defence Therapeutics Inc. |
Lefrancois, Philippe
4 - Director of Issuer
Holder: Gestion Philippe Lefrancois Inc. (Indirect Ownership)
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-09-30 13:21 Tx date 2024-09-27 |
$DTC
Defence Therapeutics Inc. |
De, Arnab
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
100,000 | ||
| Filed 2024-06-10 12:53 Tx date 2024-06-07 |
$DTC
Defence Therapeutics Inc. |
Meagher, Patrick Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Meagher Consulting Inc (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,849
+2,500 vol $1.14 each |
9,100 | |
| Filed 2024-05-30 22:48 Tx date 2024-05-29 |
$DTC
Defence Therapeutics Inc. |
Meagher, Patrick Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Meagher Consulting Inc (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,449
+3,000 vol $1.15 each |
6,600 | |
| Filed 2024-05-30 22:48 Tx date 2024-05-28 |
$DTC
Defence Therapeutics Inc. |
Meagher, Patrick Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Meagher Consulting Inc (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,212
+3,600 vol $1.17 each |
3,600 | |
| Filed 2024-05-30 22:47 Tx date 2021-04-30 |
$DTC
Defence Therapeutics Inc. |
Meagher, Patrick Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Meagher Consulting Inc (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-05-23 15:04 Tx date 2024-05-23 |
$DTC
Defence Therapeutics Inc. |
Grauer, Daniel Kwin
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,625
+8,500 vol $1.25 each |
18,500 | |
| Filed 2023-12-22 17:06 Tx date 2023-12-21 |
$DTC
Defence Therapeutics Inc. |
Meterissian, Sarkis
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$125,000
+100,000 vol $1.25 each |
192,000 | |
| Filed 2023-12-22 17:05 Tx date 2023-12-21 |
$DTC
Defence Therapeutics Inc. |
Meterissian, Sarkis
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-100,000 vol |
200,000 | |
| Filed 2023-12-15 15:02 Tx date 2023-12-13 |
$DTC
Defence Therapeutics Inc. |
Meterissian, Sarkis
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$85,000
+68,000 vol $1.25 each |
92,000 | |
| Filed 2023-12-15 15:01 Tx date 2023-12-13 |
$DTC
Defence Therapeutics Inc. |
Meterissian, Sarkis
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-68,000 vol |
300,000 | |
| Filed 2023-12-13 14:43 Tx date 2023-12-08 |
$DTC
Defence Therapeutics Inc. |
Meterissian, Sarkis
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-16,500
-6,000 vol $2.75 each |
24,000 | |
| Filed 2023-11-24 14:23 Tx date 2023-11-20 |
$DTC
Defence Therapeutics Inc. |
Meterissian, Sarkis
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,340
-2,000 vol $2.67 each |
30,000 | |
| Filed 2023-11-15 15:12 Tx date 2023-11-15 |
$DTC
Defence Therapeutics Inc. |
Meterissian, Sarkis
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$40,000
+32,000 vol $1.25 each |
32,000 | |
| Filed 2023-11-15 15:12 Tx date 2021-04-30 |
$DTC
Defence Therapeutics Inc. |
Meterissian, Sarkis
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-11-15 15:11 Tx date 2023-11-15 |
$DTC
Defence Therapeutics Inc. |
Meterissian, Sarkis
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-32,000 vol |
368,000 | |
| Filed 2023-10-26 02:13 Tx date 2023-10-23 |
$DTC
Defence Therapeutics Inc. |
Beaudoin, Simon
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$62,500
+50,000 vol $1.25 each |
50,000 | |
| Filed 2023-10-26 02:12 Tx date 2023-10-23 |
$DTC
Defence Therapeutics Inc. |
Beaudoin, Simon
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-50,000 vol |
100,000 | |
| Filed 2023-10-11 19:48 Tx date 2023-10-06 |
$DTC
Defence Therapeutics Inc. |
Meagher, Patrick Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,000,000
+400,000 vol $2.50 each |
600,000 | |
| Filed 2023-10-11 19:08 Tx date 2023-10-06 |
$DTC
Defence Therapeutics Inc. |
Loebenberg, Raimar
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+200,000 vol |
400,000 | |
| Filed 2023-10-11 19:05 Tx date 2023-10-06 |
$DTC
Defence Therapeutics Inc. |
Meterissian, Sarkis
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+200,000 vol |
400,000 | |
| Filed 2023-10-11 19:03 Tx date 2023-10-06 |
$DTC
Defence Therapeutics Inc. |
Beaudoin, Simon
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
150,000 | |
| Filed 2023-10-11 18:56 Tx date 2023-10-09 |
$DTC
Defence Therapeutics Inc. |
Rafei, Moutih
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-50,000 vol |
550,000 | |
| Filed 2023-10-11 18:55 Tx date 2023-10-06 |
$DTC
Defence Therapeutics Inc. |
Rafei, Moutih
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+400,000 vol |
600,000 | |
| Filed 2023-10-11 13:46 Tx date 2023-10-06 |
$DTC
Defence Therapeutics Inc. |
Grauer, Daniel Kwin
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+200,000 vol |
300,000 | |
| Filed 2023-10-11 13:13 Tx date 2023-10-09 |
$DTC
Defence Therapeutics Inc. |
Cesarone, Carrie
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$62,500
+50,000 vol $1.25 each |
116,000 | |
| Filed 2023-10-11 13:12 Tx date 2023-10-06 |
$DTC
Defence Therapeutics Inc. |
Cesarone, Carrie
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
150,000 | |
| Filed 2023-10-11 13:10 Tx date 2023-10-09 |
$DTC
Defence Therapeutics Inc. |
Cesarone, Carrie
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-50,000 vol |
100,000 | |
| Filed 2023-10-10 20:28 Tx date 2023-10-09 |
$DTC
Defence Therapeutics Inc. |
Meagher, Patrick Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$25,000
+20,000 vol $1.25 each |
370,000 | |
| Filed 2023-10-10 20:27 Tx date 2023-10-09 |
$DTC
Defence Therapeutics Inc. |
Meagher, Patrick Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-225,000
-180,000 vol $1.25 each |
0 | |
| Filed 2023-10-10 20:27 Tx date 2023-10-09 |
$DTC
Defence Therapeutics Inc. |
Meagher, Patrick Joseph
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-25,000
-20,000 vol $1.25 each |
180,000 | |
| Filed 2023-10-10 13:47 Tx date 2023-10-09 |
$DTC
Defence Therapeutics Inc. |
Plouffe, Sébastien
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-400,000 vol |
800,000 | |
| Filed 2023-10-07 13:35 Tx date 2023-10-06 |
$DTC
Defence Therapeutics Inc. |
Plouffe, Sébastien
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+800,000 vol |
1,200,000 | |
| Filed 2023-07-24 16:00 Tx date 2023-07-24 |
$DTC
Defence Therapeutics Inc. |
Grauer, Daniel Kwin
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,000
+2,500 vol $2.80 each |
10,000 | |
| Filed 2023-05-10 18:17 Tx date 2023-05-08 |
$DTC
Defence Therapeutics Inc. |
Grauer, Daniel Kwin
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,250
+2,500 vol $2.90 each |
7,500 | |
| Filed 2023-03-31 10:41 Tx date 2023-03-30 |
$DTC
Defence Therapeutics Inc. |
Grauer, Daniel Kwin
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,800
+2,800 vol $3.50 each |
5,000 | |
| Filed 2023-03-23 10:56 Tx date 2023-03-20 |
$DTC
Defence Therapeutics Inc. |
Grauer, Daniel Kwin
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,700
+2,200 vol $3.50 each |
2,200 | |
| Filed 2023-03-23 10:55 Tx date 2022-12-08 |
$DTC
Defence Therapeutics Inc. |
Grauer, Daniel Kwin
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-01-13 15:34 Tx date 2022-12-08 |
$DTC
Defence Therapeutics Inc. |
Grauer, Daniel Kwin
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
100,000 | ||
| Filed 2021-11-10 14:35 Tx date 2021-11-09 |
$DTC
Defence Therapeutics Inc. |
Shammaa, Riam
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
50,000 |